Testosterone substitution in male hypogonadism is a recognized tool to treat symptomatic patients. Various forms of this treatment exist including a long-acting intramuscular form using testosterone undecanoate given at approximately 3-monthly intervals. Safety aspects inherent to the intramuscular injection of a medication in an oily vehicle have to be recognized.
